Home > Financial Ratios > LYKA LABS

LYKA LABS
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 6.668.638.02-4.12-4.15

What is the latest Working Capital/Sales ratio of LYKA LABS ?

The latest Working Capital/Sales ratio of LYKA LABS is 6.66 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20256.66
Mar20248.63
Mar20238.02
Mar2022-4.12
Mar2021-4.15

How is Working Capital/Sales of LYKA LABS Trending?

Years Working Capital/Sales % Change
Mar2025 6.66
-22.83
Mar2024 8.63
7.61
Mar2023 8.02
Positive
Mar2022 -4.12
Negative
Mar2021 -4.15 -

Other Financial Ratios of LYKA LABS


Compare Working Capital/Sales ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹360.2 Cr 1.1% -13.3% -32% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹375,388.0 Cr -2.2% -8.3% -13.1% Stock Analytics
DIVIS LABORATORIES ₹162,513.0 Cr -1.1% -7.3% 21.6% Stock Analytics
CIPLA ₹126,733.0 Cr -0.7% 1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,292.0 Cr -0.5% -4.2% 4.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,935.0 Cr -0.5% -1.1% -7.7% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

1.1%

-13.3%

-32%

SENSEX

-1.8%

-1.6%

-2%


You may also like the below Video Courses